Negócios · 14/08/20151 min de leitura
National Mammography Quality Assurance Advisory Committee, Renewal
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the renewal of the National Mammography Quality Assurance Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the National Mammography Quality Assurance Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until July 6, 2017.